MUC5AC and asthma: In bronchoalveolar lavage (BAL) fluid from patients with mild-to-moderate asthma, TCEP rapidly depolymerizes MUC5AC and MUC5B (Supplementary Fig. 7), demonstrating the presence of targets in asthma patients even under stable disease conditions.